Your browser doesn't support javascript.
loading
A Chemical Modulator of p53 Transactivation that Acts as a Radioprotective Agonist.
Morita, Akinori; Takahashi, Ippei; Sasatani, Megumi; Aoki, Shin; Wang, Bing; Ariyasu, Shinya; Tanaka, Kaoru; Yamaguchi, Tetsuji; Sawa, Akiko; Nishi, Yurie; Teraoka, Tatsuro; Ujita, Shohei; Kawate, Yosuke; Yanagawa, Chihiro; Tanimoto, Keiji; Enomoto, Atsushi; Nenoi, Mitsuru; Kamiya, Kenji; Nagata, Yasushi; Hosoi, Yoshio; Inaba, Toshiya.
Afiliação
  • Morita A; Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. morita@tokushima-u.ac.jp.
  • Takahashi I; Department of Biomedical Science and Technology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Sasatani M; Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Aoki S; Department of Radiation Oncology, Hiroshima University, Hiroshima, Japan.
  • Wang B; Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Ariyasu S; Department of Medicinal and Life Science, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Tanaka K; Center for Technologies against Cancer, Tokyo University of Science, Chiba, Japan.
  • Yamaguchi T; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
  • Sawa A; Center for Technologies against Cancer, Tokyo University of Science, Chiba, Japan.
  • Nishi Y; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
  • Teraoka T; Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Ujita S; Department of Medicinal and Life Science, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Kawate Y; Department of Medicinal and Life Science, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Yanagawa C; Department of Medicinal and Life Science, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
  • Tanimoto K; Department of Biomedical Science and Technology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Enomoto A; Department of Biomedical Science and Technology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Nenoi M; Department of Biomedical Science and Technology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Kamiya K; Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Nagata Y; Laboratory of Molecular Radiology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Hosoi Y; National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan.
  • Inaba T; Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Mol Cancer Ther ; 17(2): 432-442, 2018 02.
Article em En | MEDLINE | ID: mdl-28939557

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protetores contra Radiação / Proteína Supressora de Tumor p53 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protetores contra Radiação / Proteína Supressora de Tumor p53 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article